Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Investigation of the Cellular Immune Response to Recombinant Fragments of Filamentous Hemagglutinin and Pertactin of Bordetella Pertussis in Balb/C Mice Publisher Pubmed



Bakhshaei P1 ; Kazemi MH1 ; Golara M1 ; Abdolmaleki S1 ; Khosravieghbal R1 ; Khoshnoodi J1 ; Judaki MA1 ; Salimi V2 ; Douraghi M3 ; Jedditehrani M4 ; Shokri F1, 4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Immunology, School of Public Health, Tehran University of Medical Sciences, PO Box 6446-14155, Tehran, 1416753955, Iran
  2. 2. Department of Virology, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Department of Microbiology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Hybridoma Department, Monoclonal Antibody Research Center, Avicenna Research Institute, ACECR, Tehran, Iran

Source: Journal of Interferon and Cytokine Research Published:2018


Abstract

Vaccination with whole-cell or acellular (Ac) vaccines has been very effective for the control of pertussis. The immune response to Ac vaccines has been generally associated with a shift toward the Th2 profile. In the present study, overlapping recombinant fragments of filamentous hemagglutinin (FHA) and pertactin (PRN) were produced in Escherichia coli. BALB/c mice were immunized with recombinant FHA and PRN together with the native pertussis toxin and alum or CpG as adjuvant. Immunized mice were subsequently aerosol challenged with Bordetella pertussis. Bacterial growth was assessed in bronchoalveolar lavage samples and the levels of cytokines were quantitated in supernatants of stimulated splenocytes by enzyme-linked immunosorbent assay. Our results demonstrated that both PRN and FHA antigens were able to induce IFN-γ, IL-4, and to some extent IL-17 cytokines in challenged mice. The level of IFN-γ was higher in response to CpG formulated antigens. These findings indicate immunoprotective efficacy of our recombinant FHA and PRN antigens in mice. © Copyright 2018, Mary Ann Liebert, Inc. 2018.